EXTENDED RELEASE MIDODRINE HYDROCHLORIDE COMPOSITIONS AND METHODS OF USE
This disclosure provides pharmaceutical compositions comprising midodrine, a pharmaceutically acceptable salt thereof, desglymidodrine, or a pharmaceutically acceptable salt thereof, that can be administered to a human subject in need thereof. The disclosure also provides pharmaceutical compositions...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
27.06.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This disclosure provides pharmaceutical compositions comprising midodrine, a pharmaceutically acceptable salt thereof, desglymidodrine, or a pharmaceutically acceptable salt thereof, that can be administered to a human subject in need thereof. The disclosure also provides pharmaceutical compositions for treatment of orthostatic hypotension that can be administered once or twice a day.
La présente invention concerne des compositions pharmaceutiques comportant de la midodrine, un sel de qualité pharmaceutique de celle-ci, de la desglymidodrine, ou un sel de qualité pharmaceutique de celle-ci, et qui peuvent être administrées à un patient humain en ayant besoin. L'invention concerne également des compositions pharmaceutiques destinées au traitement de l'hypotension orthostatique et qui peuvent être administrées une ou deux fois par jour. |
---|---|
Bibliography: | Application Number: WO2018US67323 |